Osmo secured 70 million USD in Series B funding, bringing its total capital to 130 million USD to sc...
The AMW Read
The article updates the player map for Vertical AI (Healthcare/Bio) via Osmo's $70M Series B, though it falls below the $500M threshold for cross.§D capital tagging.
NoveltySignificance
Healthcare & Bio · Player Map
Osmo secured 70 million USD in Series B funding, bringing its total capital to 130 million USD to scale its Olfactory Intelligence platform. By mapping the molecular structure of scents with AI, the company is digitizing a 50 billion USD manual industry to enable efficient formula creation and manufacturing. The systemic impact reaches far beyond consumer fragrance, establishing a technical foundation for non-invasive medical diagnostics and automated environmental monitoring. 🌐🔬